BioRem Inc. (BRM) — Capital Reinvestment Ratio

Latest as of December 2025: 0.01x

BioRem Inc. (BRM) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$3.38 Million) in capital expenditures (CA$28.22K). See BioRem Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

CA$3.38 Million
CAD

Capital Expenditures

CA$28.22K
CAD

Data as of

Dec 2025
Most recent filing

BioRem Inc. Capital Reinvestment Ratio (2006–2025)

This chart tracks BioRem Inc.'s Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for BioRem Inc. (2006–2025)

Year-by-year Capital Reinvestment Ratio for BioRem Inc. from 2006 to 2025. For live market cap and broader valuation context, see BRM company net worth.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2025 0.05x CA$7.64 Million CA$367.83K ▼ -52.3%
2024 0.10x CA$3.69 Million CA$372.00K ▼ -91.1%
2023 1.13x CA$490.03K CA$552.87K ▲ +701.9%
2022 0.14x CA$1.44 Million CA$203.29K ▲ +600.3%
2021 0.02x CA$3.78 Million CA$75.98K ▼ -80.4%
2020 0.10x CA$3.34 Million CA$342.40K ▲ +91.9%
2019 0.05x CA$2.53 Million CA$135.23K ▲ +337.8%
2017 0.01x CA$1.17 Million CA$14.34K ▲ +306.4%
2015 0.00x CA$2.15 Million CA$6.46K ▼ -91.5%
2013 0.04x CA$733.71K CA$25.93K ▼ -89.8%
2011 0.34x CA$905.26K CA$312.24K ▲ +151.0%
2009 0.14x CA$2.12 Million CA$291.78K ▼ -52.6%
2006 0.29x CA$1.15 Million CA$333.77K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow